Health risk assessment of fungi in home environments

Annals of Allergy, Asthma and Immunology

Volumn 78, Issue 6, 1997, Pages 544-556

  Verhoeff, Arnoud P ^a   Burge, Harriet A ^b  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA 1,3 GLUCAN; MYCOTOXIN;

AIR POLLUTANT; AIR SAMPLING; ALLERGY; ASTHMA; ENVIRONMENTAL EXPOSURE; FUNGUS; FUNGUS IDENTIFICATION; HEALTH HAZARD; HOME; HOUSE DUST; HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SKIN TEST; WHEEZING;

EID: 0030940288     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63214-0     Document Type: Review

References (67)

1. Spengler JD. Outdoor and indoor air pollution. In: Tarcher AB, ed. Principles and practice of environmental medicine. New York: Plenum Medical Book Company, 1992:21-41.
2. Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution, I. Am Rev Respir Dis 1987;136:1486-508.
3. Samet JM, Marburry MC, Spengler JD. Health effects and sources of indoor air pollution, II. Am Rev Respir Dis 1988;137:221-42.
4. Burge H. Bioaerosols: prevalence and health effects in the indoor environment. J Allergy Clin Immunol 1990; 86:687-701.
5. Burge HA. Aerobiology of the indoor environment. Occup Med 1995;10: 27-40.
6. Commission of the European Communities. Biological particles in indoor environments. European Collaborative Action Indoor Air Quality and Its Impact on Man, Report No. 12, Brussels, Luxembourg, 1993.
7. Pope AM, Patterson R, Burge H, eds. Indoor allergens. Assessing and controlling adverse health effects. Washington: National Academy Press, 1993.
8. Brunekreef B, Dockery DW, Speizer FE, et al. Home dampness and respiratory morbidity in children. Am Rev Respir Dis 1989;140:1363-67.
9. Dales RE, Zwanenburg H, Burnett R, Franklin CA. Respiratory health effects of home dampness and molds among Canadian children. Am J Epidemiol 1991;134:196-203.
10. Spengler J, Neas L, Nakai S, et al. Respiratory symptoms and housing characteristics. Indoor Air 1994;4: 72-82.
11. Strachan DP. Damp housing and childhood asthma: validation of reporting of symptoms. Br Med J 1988;297: 1223-6.
12. Brunekreef B. Associations between questionnaire reports of home dampness and childhood respiratory symptoms. Sci Total Environ 1992;127: 79-89.
13. Jaakkola JJK, Jaakkola N, Ruotsalainen R. Home dampness and molds as determinants of respiratory symptoms and asthma in pre-school children. J Exp Analysis Environ Epidemiol 1993;3,Suppl 1:129-42.
14. Verhoeff AP, Van Strien RT, Van Wijnen JH, Brunekreef B. Damp housing and childhood respiratory symptoms: the role of sensitization to dust mites and molds. Am J Epidemiol 1995;141:103-10.
15. Hunter CA, Grant C, Flannigan B, Bravery AF. Mould in buildings: the air spora of domestic dwellings. Int Biodeterior 1988;24:81-101.
16. Platt SD, Martin CJ, Hunt SM, Lewis CW. Damp housing, mould growth, and symptomatic health state. Br Med J 1989;298:1673-8.
17. Waegemaekers M, Van Wageiningen N, Brunekreef B, Boleij JSM. Respiratory symptoms in damp homes. A pilot study. Allergy 1989;44:192-8.
18. Verhoeff AP, Van Wijnen JH, Brunekreef B, et al. The presence of viable mould propagules in indoor air in relation to house damp and outdoor air. Allergy 1992;47:83-91.
19. Salvaggio J, Aukrust L. Mold-induced asthma. J Allergy Clin Immunol 1981; 68:327-46.
20. Tobin RS, Baranowski E, Gilman AP, et al. Significance of fungi in indoor air: report of a working group. Can J Public Health 1987;78:s1-s14.
21. Burge HA. Airborne allergenic fungi. Classification, nomenclature, and distribution. Immunol Allergy Clin N Am 1989;9:307-19.
22. Miller JD. Fungi as contaminants in indoor air. Atmospheric Environ 1992; 26A:2163-72.
23. Flannigan B, Miller JD. Health implications of fungi in indoor environments. An overview. In: Samson RA, Flannigan B, Flannigan ME, et al, eds. Health implications of fungi in indoor environments. Air Quality Monographs. Vol 2. Amsterdam: Elsevier, 1994:3-28.
24. Barbee RA, Lebowitz MD, Thompson HC, Burrows B. Immediate skin-test reactivity in a general population sample. Ann Intern Med 1976;84:129-33.
25. Sears MR, Herbison GP, Holdaway MD, et al. The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 1989;19:419-24.
26. Gravesen S. Fungi as a cause of allergic disease. Allergy 1979;34:135-54.
27. Beaumont F, Kauffman HF, Sluiter HJ, De Vries K. Volumetric aerobiological survey of conidial fungi in the North-East Netherlands. II. Comparison of aerobiological data and skin tests with mould extracts in an asthmatic population. Allergy 1985;40: 181-6.
28. Nordvall SL, Eriksson M, Rylander E, Strömquist L-H. Fungal allergy in children. J Pediatr Allergy Immunol 1990; 1:68-73.
29. Niemeijer NR, De Monchy JGR. Age-dependency of sensitization to aeroallergens in asthmatics. Allergy 1992; 47:431-5.
30. Kauffman HF, Zuidema S, De Monchy JGR. Clinical significance of fungi in asthma: aerobiology and clinical studies. In: Samson RA, Flannigan B, Flannigan ME, eds. Health implications of fungi in indoor environments. Air Quality Monographs. Vol 2. Amsterdam: Elsevier, 1994:221-8.
31. Baldo BA. Allergenic crossreactivity of fungi with emphasis on yeasts: strategies for further study. Clin Exp Allergy 1995;25:488-92.
32. Rylander R, Persson K, Goto H, et al. Airborne beta-1,3-glucan may be related to symptoms in sick buildings. Indoor Environ 1992;1:263-7.
33. IARC. Some naturally occurring substances: some food items and constituents, heterocyclic amines and mycotoxins. IARC Monograph 56, IARC, Lyon, 1993.
34. Croft WA, Jarvis BB, Yatawara CS. Airborne outbreak of trichothecene toxicosis. Atm Environ 1986;20: 549-52.
35. Etzel R, Montana E, Sorenson WG, et al. Pulmonary hemosiderosis associated with exposure to Stachybotrys atra. [Abstract] Epidemiology 1996; 7,S38.
36. Flannigan B, McGabe EM, McGarry F. Allergenic and toxigenic microorganisms in houses. J Appl Bacteriol 1991;70:61s-73s.
37. Summerbell RC, Staib F, Dales R, et al. Ecology of fungi in human dwellings. J Med Vet Mycol 1992;30:Suppl. 1,279-85.
38. Rao C, Burge HA, Chang J. Review of quantitative standards and guidelines for fungi in indoor air. J Air Water Waste Management Assoc 1996;46: 899-908.
39. Björnsson E, Norbäck D, Janson C, et al. Asthmatic symptoms and indoor levels of micro-organisms and house dust mites. Clin Exp Allergy 1995;25: 423-31.
40. Wood RA, Eggleston PA, Lind P, et al. Antigenic analysis of house dust samples. Am Rev Respir Dis 1988;137: 358-63.
41. Strachan DP, Flannigan B, McCabe EM, McGarry F. Quantification of airborne moulds in the homes of children with and without wheeze. Thorax 1990;45:382-7.
42. Li C-S, Hsu L-Y, Chou C-C, Hsieh K-H. Fungus allergens inside and outside the residences of atopic and control children. Arch Environ Health 1995;50:38-43.
43. Su HJ, Rotnitzky A, Burge HA, Spengler JD. Examination of fungi in domestic interiors by using factor analysis: correlations and associations with home factors. Appl Environ Microbiol 1992;58:181-6.
44. Verhoeff AP, Van Wijnen JH, Van Reenen-Hoekstra ES, et al. Fungal propagules in house dust. II. Relation with residential characteristics and respiratory symptoms. Allergy 1994;49: 540-7.
45. Wickmann M, Gravesen S, Nordvall SL, et al. Indoor viable dust-bound microfungi in relation to residential characteristics, living habits, and symptoms in atopic and control children. J Allergy Clin Immunol 1992;89:752-9.
46. Palmgren U, Ström G, Blomqvist G, Malmberg P. Collection of airborne micro-organisms on Nucleopore filters, estimation and analysis. CAMNBA method. J Appl Bacteriol 1986; 61:401-6.
47. Güneser S, Atici A, Köksal F, Yaman A. Mold allergy in Adana, Turkey. Allergol Immunopathol 1994;22:52-4.
48. Yoshida K, Ando M, Sakata T, Araki S. Environmental mycological studies on the causative agent of summer-type hypersensitivity pneumonias. J Allergy Clin Immunol 1988;81:475-83.
49. Burr ML, Mullins J, Merrett TG, Stott NCH. Indoor moulds and asthma. J Roy Soc Health 1988;3:99-101.
50. Tarlo SM, Fradkin A, Tobin RS. Skin testing with extracts of fungal species derived from the homes of allergy clinic patients in Toronto. Canada. Clin Allergy 1988;18:45-52.
51. Zwick H, Popp W, Braun O, et al. Personal spore sampling and indirect immunofluorescent test for exploration of hypersensitivity pneumonitis due to mould spores. Allergy 1991;46: 277-83.
52. Beaumont F, Kauffman HF, Sluiter HJ, De Vries K. Sequential sampling of fungal air spores inside and outside the homes of mould-sensitive, asthmatic patients: a search for a relationship to obstructive reactions. Ann Allergy 1985;55:740-6.
53. Holst PE, Coleman ED, Sheridan JE, et al. Asthma and fungi in the home. N Z Med J 1983;96:718-20.
54. Delfino RJ, Coate BD, Zeiger RS, et al. Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores. Am J Respir Crit Care Med 1996;154:633-41.
55. Sandford A, Weir T, Paré P. The genetics of asthma. Am J Respir Crit Care Med 1996;153:1749-65.
56. Verhoeff AP, Van Strien TR, Van Wijnen JH, Brunekreef B. House dust mite allergen (Der p I) and respiratory symptoms in children: a case-control study. Clin Exp Allergy 1994;24: 1016-69.
57. Verhoeff AP, Van Wijnen JH, Boleij JSM, et al. Enumeration and identification of airborne viable mould propagules in houses; a field comparison of selected techniques. Allergy 1990;45: 275-84.
58. Macher JM, Chatigny MA, Burge HA. Sampling airborne microorganisms and aeroallergens. In: Cohen BS, Hering SV, eds. Air sampling instruments for evaluation of atmospheric contaminants. 8th Edition. Cincinnati. ACGIH 1995;589-617.
59. Nevalainen A, Pastuszka J, Liebhaber F, Willeke K. Performance of bioaerosol samplers: collection characteristics and sampler design considerations. Atm Environ 1992;26A:531-40.
60. Verhoeff AP, Van Reenen-Hoekstra ES, Samson RA, et al. Fungal propagules in house dust. I. Comparison of analytic methods and their value as estimators of potential exposure. Allergy 1994;49:533-9.
61. Chew G, Muilenberg M, Gold D, Burge HA. Is dust sampling a good surrogate for exposure to airborne fungi? [Abstract] J Allergy Clin Immunol 1996;97:419.
62. Mailing H-J, Agrell B, Croner S, et al. Diagnosis and immunotherapy of mould allergy. I. Screening for mould allergy. Allergy 1985;40:108-14.
63. Yunginger JW, Jones RT, Gleich GJ. Studies on Alternaria allergens. II. Measurement of commercial Alternaria extracts by the direct RAST and RAST inhibition. J Allergy CHn Immunol 1976;74:256-61.
64. Douwes J, Doekes G, Montijn R, et al. Measurement of environmental ψ(1->3)-glucans in occupational and home environments with an inhibition enzyme immunoassay. Appl Environ Microbiol 1996;62:3176-82.
65. Miller JD, Laflamme AM, Sobol Y, et al. Fungi and fungal products in some Canadian houses. Int Biodeterior 1988; 24:103-20.
66. Doekes G, Van der Sluis B, Wijnands LM, et al. Indoor mold exposure assessment with the use of enzyme Immunoassays for mold extracellular polysaccharides (EPS) in house dust [Abstract]. 1995;50(Suppl 26):73.
67. Notermans S, Dufrenne J, Wijnands LM, Engel HWB. Human serum antibodies to extracellular polysaccharides (EPS) of moulds. J Med Vet Mycol 1988;26:41-8.